Relevant Adverse Events and Drug Discontinuation of Sacubitril/Valsartan in Patients with Transthyretin Amyloid Cardiomyopathy - Insights from the REVIEW-HF Registry
International Heart Journal · 30.05.2026 · 67 (3) · 221-227
DOI: 10.1536/ihj.25-686 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Heart Journal, erschienen am 30.05.2026. Verfasst von Yukihiro Watanabe und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Nippon Medical School. Hauptthemen laut MEDLINE: Aminobutyrates, Amyloid Neuropathies, Familial, Angiotensin Receptor Antagonists, Cardiomyopathies. Die Arbeit nennt 25 Literaturangaben.
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Nippon Medical School.
- Division of Cardiovascular Intensive Care, Nippon Medical School Hospital.
- Division of Cardiology, Department of Internal Medicine, Iwate Medical University.
- Department of Cardiovascular Medicine, Kitasato University School of Medicine.
- Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine.
- Department of Digital Health and Telemedicine, R&D.
Zitieren
APA
Watanabe, Y., Kubota, Y., Murata, H., Uchiyama, S., Asai, K., Nasu, T., Ishii, S., Kagiyama, N., Kida, K., Fujimoto, W., Kikuchi, A., Ijichi, T., Shibata, T., Kanaoka, K., & Matsumoto, S. (2026). Relevant Adverse Events and Drug Discontinuation of Sacubitril/Valsartan in Patients with Transthyretin Amyloid Cardiomyopathy - Insights from the REVIEW-HF Registry. International Heart Journal, 67(3), 221-227. https://doi.org/10.1536/ihj.25-686
Vancouver
Watanabe Y, Kubota Y, Murata H, Uchiyama S, Asai K, Nasu T, et al. Relevant Adverse Events and Drug Discontinuation of Sacubitril/Valsartan in Patients with Transthyretin Amyloid Cardiomyopathy - Insights from the REVIEW-HF Registry. International Heart Journal. 2026;67(3):221-227. doi:10.1536/ihj.25-686
BibTeX
@article{Watanabe2026,
author = {Watanabe, Yukihiro and Kubota, Yoshiaki and Murata, Hiroshige and Uchiyama, Saori and Asai, Kuniya and Nasu, Takahito and Ishii, Shunsuke and Kagiyama, Nobuyuki and Kida, Keisuke and Fujimoto, Wataru and Kikuchi, Atsushi and Ijichi, Takeshi and Shibata, Tatsuhiro and Kanaoka, Koshiro and Matsumoto, Shingo},
title = {Relevant Adverse Events and Drug Discontinuation of Sacubitril/Valsartan in Patients with Transthyretin Amyloid Cardiomyopathy - Insights from the REVIEW-HF Registry},
journal = {International Heart Journal},
year = {2026},
volume = {67},
number = {3},
pages = {221--227},
doi = {10.1536/ihj.25-686}
}
EUVIMED